Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress

Free Radical Biology and Medicine

Volumn 43, Issue 1, 2007, Pages 71-79

  Bergamo, Paolo ^a   Maurano, Francesco ^a   Rossi, Mauro ^a  

^a CNR   (Italy)

Author keywords

Chemoprotection; Conjugated linoleic acid; Lupus erythematosus; Oxidative stress; Phase 2 enzymes

Indexed keywords

3 NITROTYROSINE; CONJUGATED LINOLEIC ACID; DOUBLE STRANDED DNA ANTIBODY; GAMMA GLUTAMYLCYSTEINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LINOLEIC ACID; OLEIC ACID; OLIVE OIL; OXIDOREDUCTASE; PALMITIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; LIVER; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIOXIDANTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LINOLEIC ACIDS, CONJUGATED; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; NADPH DEHYDROGENASE; OXIDATIVE STRESS; SPLEEN;

ANIMALIA; MUS;

EID: 34249877687     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.03.023     Document Type: Article

References (63)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
2. Gilkeson G., Cannon C., Oates J., Reilly C., Goldman D., and Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J. Rheumatol. 26 (1999) 318-324
3. Morgan P.E., Sturgess A.D., and Davies M.J. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 2069-2079
4. Weinberg J.B., Gilkeson G.S., Mason R.P., and Chamulitrat W. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. Free Radic. Biol. Med. 24 (1998) 191-196
5. Venkatraman J.T., Chandrasekar B., Kim J.D., and Fernandes G. Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmune-prone MRL/MpJ-lpr/lpr mice. Biochim. Biophys. Acta 1213 (1994) 167-175
6. Keng T., Privalle C.T., Gilkeson G.S., and Weinberg J.B. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol. Med. 6 (2000) 779-792
7. Dinkova-Kostova A.T., Liby K.T., Stephenson K.K., Holtzclaw W.D., Gao X., Suh N., Williams C., Risingsong R., Honda T., Gribble G.W., Sporn M.B., and Talalay P. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci. USA 102 (2005) 4584-4589
8. Chen X.-L., and Kunsch C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr. Pharm. Des. 10 (2004) 879-891
9. Ketterer B. The role of nonenzymatic reactions of glutathione in xenobiotic metabolism. Drug Metab. Rev. 13 (1982) 161-187
10. Meister A. Selective modification of glutathione metabolism. Science 220 (1983) 472-477
11. Ziegler D.M. Role of reversible oxidation-reduction cycle of enzyme thiols-disulphides in metabolism regulation. Annu. Rev. Biochem. 54 (1985) 305-329
12. Reed D.J., and Fariss M.W. Glutathione depletion and susceptibility. Pharmacol. Rev. 36 (1984) 25S-33S
13. Arrigo A.P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27 (1999) 936-944
14. Pastore A., Federici G., Bertini E., and Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 333 (2003) 19-39
15. Gambhir J.K., Lali P., and Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin. Biochem. 30 (1997) 351-352
16. Giustarini D., Lorenzini S., Rossi R., Chindamo D., Di Simplicio P., and Marcolongo R. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin. Exp. Rheumatol. 23 (2005) 205-212
17. Fidelus R.K., and Tsan M.F. Glutathione and lymphocyte activation: a function of ageing and auto-immune disease. Immunology 61 (1987) 503-508
18. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.-M., and Hagen T.M. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. USA 9 (2004) 3381-3386
19. Yoh K., Itoh K., Enomoto A., Hirayama A., Yamaguchi N., Kobayashi M., Morito N., Koyama A., Yamamoto M., and Takahashi S. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 60 (2001) 1343-1353
20. Li J., Stein T.D., and Johnson J.A. Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiol. Genomics 18 (2004) 261-272
21. Ha Y.L., Grimm N.K., and Pariza M.W. Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8 (1987) 1881-1887
22. lpr mice. J. Lipid Res. 47 (2006) 2382-2391
23. Wahle K.W.J., Heys S.D., and Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog. Lipid Res. 43 (2004) 553-587
24. Zvonic S., Cornelius P., Stewart W.C., Mynatt R.L., and Stephens J.M. Effects of cardiotrophin on adipocytes. J. Biol. Chem. 279 (2004) 47572-47579
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
26. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. (Lond.) 84 (1993) 407-412
27. Piredda L., Amendola A., Coalizzi V., Davies P., Farrace M.G., Fraziano M., Gentile V., Uray I., Piacentini M., and Fesus L. Lack or "tissue" transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRL/lpr mice. Cell Death Differ. 4 (1997) 463-472
28. Khan J., Brennan D.M., Bradley N., Gao B., Bruckdorfer R., and Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 330 (1998) 795-801
29. Ye Y.Z., Strong M., Huang Z.Q., and Beckman J.S. Antibodies that recognize nitrotyrosine. Methods Enzymol. 269 (1996) 201-209
30. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltier S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186 (1990) 464-478
31. Bergamo P., Luongo D., Maurano F., and Rossi M. Butterfat fatty acids differentially regulate growth and differentiation in Jurkat T cells. J. Cell. Biochem. 96 (2005) 349-360
32. Benson A.M., Hunkeler M.J., and Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77 (1980) 5216-5220
33. Habig W.H., and Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77 (1981) 398-405
34. Seelig G.F., and Meister A. Gamma-glutamylcysteine synthetase. Interactions of an essential sulfhydryl group. J. Biol. Chem. 259 (1984) 3534-3538
35. Lim S.Y., Jang J.H., Na H.K., Lu S.C., Rahman I., and Surh Y.J. 15-Deoxy-delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. J. Biol. Chem. 279 (2004) 46263-46270
36. Chin S.F., Storkson J.M., Albright K.J., Cook M.E., and Pariza M.W. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J. Nutr. 124 (1994) 2344-2349
37. Xie C., Lowell M.A., Xiong S., Kindi M.S., Guo J.-T., Xie J., Amaranth V., Montine T.J., and Markesbery W.R. Expression of glutathione-S-transferase isozyme in the Sy5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic. Biol. Med. 31 (2001) 73-81
38. Xia C., Hu J., Ketterer B., and Taylor J.B. The organization of the human GSTP 1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313 (1996) 155-161
39. Reilly C.M., Farrelly L.W., Viti D., Redmond S.T., Hutchison F., Ruiz P., Manning P., Connor J., and Gilkeson G.S. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int. 61 (2002) 839-846
40. Kurien B.T., Hensley K., Bachmann M., and Scofield R.H. Oxidatively modified autoantigens in autoimmune diseases. Free Radic. Biol. Med. 41 (2006) 549-556
41. Ter Borg E.J., Horst G., Hummel E.J., Limburg P.C., and Kallenberg C.G. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum. 33 (1990) 634-643
42. Ohmori H., and Kanayama N. Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun. Rev. 4 (2005) 224-229
43. Dixit K., and Ali R. Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 13 (2004) 95-100
44. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271 (1996) C1424-C1427
45. Halliwell B. What nitrates nitrotyrosine? Is nitrotyrosine specific as biomarker of peroxynitrite formation in vivo?. FEBS Lett. 411 (1997) 157-160
46. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269 (1994) 4705-4708
47. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic. Res. Commun. 17 (1992) 221-237
48. Rajakangas J., Basu S., Salminen I., and Mutanen M. Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-kappaB and cyclin D1 protein levels in the Min mouse. J. Nutr. 133 (2003) 1943-1948
49. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Cui Y., Hennighausen L., Gonzalez F., Rohrer J., Benninghoff A.U., and Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127 (2004) 777-791
50. Yessoufou A., Soulaimann N., Merzouk S.A., Moutairou K., Ahissou H., Prost J., Simonin A.M., Merzouk H., Hichami A., and Khan N.A. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int. J. Obes. (Lond.) 30 (2006) 739-750
51. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21 (2002) 495-505
52. Field C.J., and Schley P.D. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am. J. Clin. Nutr. 79 (2004) 1190S-1198S
53. Venkatraman J.T., Bysani C., Kim J.D., and Fernandes G. Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice. Lipids 29 (1994) 561-568
54. Bhattacharya A., Lawrence R.A., Krishnan A., Zaman K., Sun D., and Fernandes G. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice. J. Am. Coll. Nutr. 22 (2003) 388-399
55. Bhattacharya A., Rahman M., Banu J., Lawrence R.A., McGuff H.S., Garrett I.R., Fischbach M., and Fernandes G. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J. Am. Coll. Nutr. 24 (2005) 200-292
56. Kim Y.J., Yokozawa T., and Chung H.Y. Suppression of oxidative stress in aging NZB/NZW mice: effect of fish oil feeding on hepatic antioxidant status and guanidino compounds. Free Radic. Res. 39 (2005) 1101-1110
57. Komatsu W., Ishihara K., Murata M., Saito H., and Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic. Biol. Med. 34 (2003) 1006-1016
58. Arab K., Rossary A., Flourie F., Tourneur Y., and Steghens J.P. Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase. Br. J. Nutr. 95 (2006) 18-26
59. Takeda Y., Takeno M., Iwasaki M., Kobayashi H., Kirino Y., Ueda A., Nagahama K., Aoki I., and Ishigatsubo Y. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin. Exp. Immunol. 138 (2004) 237-244
60. Kobayashi H., Takeno M., Saito T., Takeda Y., Kirino Y., Noyori K., Hayashi T., Ueda A., and Ishigatsubo Y. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 54 (2006) 1132-1142
61. Bergamo P., Luongo D., and Rossi M. Conjugated linoleic acid-mediated apoptosis in Jurkat T cells involves the production of reactive oxygen species. Cell. Physiol. Biochem. 14 (2004) 57-64
62. Jaiswal A.K. Nrf2 signaling in coordinated activation of gene expression. Free Radic. Biol. Med. 36 (2004) 1199-1207
63. Chen C., and Kong A.N. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol. Sci. 26 (2005) 318-326